Justera Announces Definitive Agreement to Sell Port North Extracts Inc. and Resignations

Executive Summary

• Justera Health Ltd. entered into a definitive Share and Asset Purchase Agreement to sell 100 % of the issued and outstanding shares of its wholly‑owned subsidiary, Port North Extracts Inc., to 2657953 Ontario Inc. for $1 plus assumption of all indebtedness and liabilities.
• Concurrently, Chief Executive Officer Joshua Herman and Chief Financial Officer Paul Haber resigned; Youngcho Lee is now the sole director and officer of the company.

Key Details

• Transaction Parties: Seller – Justera Health Ltd.; Purchaser – 2657953 Ontario Inc. (the “Purchaser”).
• Asset Sold: All issued and outstanding shares of Port North Extracts Inc., a wholly‑owned subsidiary of Justera.
• Purchase Price: $1 (nominal consideration) plus the Purchaser’s assumption of all of Port North’s indebtedness, borrowings, loans, and other liabilities as defined in the agreement.
• Closing Conditions: Subject to customary closing conditions, including satisfaction or waiver of regulatory approvals, consents, and any required third‑party approvals.
• Finder’s Fee: No finder’s fee is payable in connection with the transaction.
• Management Resignations:
• Joshua Herman – CEO and Director (resigned).
• Paul Haber – CFO (resigned).
• Remaining Leadership: Youngcho Lee – sole remaining director and officer of Justera Health Ltd.
• Forward‑Looking Statements: The release contains forward‑looking information regarding the completion of the transaction, regulatory approvals, integration plans, and anticipated benefits or synergies.

Notable Quotes

(No direct quotes were provided in the release.)